One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1016/j.annonc.2023.09.2413
Copy DOI Journal: Annals of Oncology |  Publication Date: Oct 1, 2023 |
Affiliation: Samsung Medical Center, Sungkyunkwan University, Centre Hospitalier Universitaire de Bordeaux, National Center for Tumor Diseases, Heidelberg University, University Hospital Heidelberg, German Center for Lung Research, Merck (Germany), Pius Hospital Oldenburg, Carl von Ossietzky University of Oldenburg, The University of Texas MD Anderson Cancer Center, Hakodate Central General Hospital, Antwerp University Hospital, Instituto Oncológico Dr. Rosell1380P Treatment (Tx) sequencing with tepotinib in previously treated patients (pts) with MET exon 14 (METex14) skipping NSCLC in the VISION trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
